Journal of Diabetes Investigation (Oct 2021)

Prospective study: Aldehyde dehydrogenase 2 gene is associated with cardio‐cerebrovascular complications in type 2 diabetes patients

  • Qingfang He,
  • Jin Pan,
  • Lixin Wang,
  • Yujia Fang,
  • Ruying Hu

DOI
https://doi.org/10.1111/jdi.13538
Journal volume & issue
Vol. 12, no. 10
pp. 1845 – 1854

Abstract

Read online

Abstract Aims/Introduction Most studies have shown that aldehyde dehydrogenase 2 (ALDH2) mutations were associated with cardio‐cerebrovascular complications of diabetes based on cross‐sectional investigations, but few studies based on cohorts were carried out. The aim of this study was to explore the correlation between the ALDH2 gene and the occurrence of and death from cardio‐cerebrovascular complications in type 2 diabetes patients through a prospective cohort study. Materials and Methods According to a community‐based and disease‐based prospective cohort study design, a baseline cohort of 10,339 persons with type 2 diabetes was established in 2016, and the occurrence of and death from cardio‐cerebrovascular complications were followed up until December 2018. A total of 2,500 diabetes patients without cardio‐cerebrovascular complications were randomly selected from the baseline cohort to detect the rs671 polymorphism of the ALDH2 gene. Cox regression analysis was carried out on the effect of different ALDH2 rs671 single‐nucleotide polymorphisms on the risk and survival time of cardio‐cerebrovascular complications among diabetes patients. Results There were 215 cardio‐cerebrovascular complications, including 10 deaths, that occurred in the 2,500 diabetes patients during the follow‐up period. Cox regression analysis showed that rs671 GA/AA genotype, sex (male), poor control of high‐density lipoprotein cholesterol, low‐density lipoprotein cholesterol, blood pressure and glycated were risk factors, whereas drinking alcohol was a protective factor for cardio‐cerebrovascular complications (P < 0.05). After adjusting for age and sex, the risk of the rs671 GA/AA genotype was 1.314‐fold (95% confidence interval 1.000–1.727) that of the GG genotype. Conclusion The G‐A mutation of ALDH2 rs671 is a risk factor for the occurrence of and death from cardio‐cerebrovascular complications in type 2 diabetes patients. Further studies with larger cohorts and longer follow up will be necessary to reveal a consensus.

Keywords